Instead, it should be combined with medical treatments, such as testosterone replacement therapy (TRT)
Dosing Protocols in Research Most gene expression studies used GHK-Cu at concentrations equivalent to: Subcutaneous injection: 12 mg/day (common biohacking protocol) Topical application: 15% concentration creams/serums (skin-focused gene effects) In vitro concentrations: 10100 nM range in cell studies For subcutaneous use, peptide community protocols typically run: Dose: 12 mg/day Cycle: 3090 days on, 30 days off Injection site: Subcutaneous, rotating sites Common stack: GHK-Cu + BPC-157 (synergistic tissue repair), GHK-Cu + MOTS-C (longevity stack), GHK-Cu + Retatrutide (body recomposition with connective tissue support) Topical use is effective for skin-specific outcomes
Ci thin lu thng mu, sc khe tim mch Ginkgo biloba c dng gii phng nng lng n cc c quan khc nhau bao gm: Gan, thn v phi
PMID: 12490959
Contributing factors include anemia, systemic inflammation, cytokine dysregulation, sleep disturbances, and cumulative psychological stress
